Date	Period	Revenue/Estimate	Earnings Call
Nov 13, 2024	2024/Q3	9.000M / --	--
May 15, 2024	2024/Q1	11.000M / --	--
Nov 13, 2023	2023/Q3	73.000M / --	--
May 15, 2023	2023/Q1	220.000M / --	--
Nov 14, 2022	2022/Q3	296.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 13, 20242024/Q39.000M / ----

May 15, 20242024/Q111.000M / ----

Nov 13, 20232023/Q373.000M / ----

May 15, 20232023/Q1220.000M / ----

Nov 14, 20222022/Q3296.000M / ----

Unlock Free Earnings Estimates

Open Account

Solasia Pharma KK Earnings Reports

Solasia Pharma KK: Notice regarding the recording of impairment losses and differences between full-year consolidated earnings forecasts and actual values for the fiscal year ending 2024/12

Feb 12 02:00 ET

Solasia Pharma KK: Summary of financial results for the fiscal year ending 2024/12 [IFRS] (consolidated)

Feb 12 02:00 ET

Solasia Pharma KK: Business status of product development products, etc. (fiscal year ending 2024/12)

Feb 12 02:00 ET

Solasia Pharma KK: Notice regarding revisions to the 2024 full-year earnings forecast

Jan 5 18:50 ET

Top JP Stock Gainers

Symbol Price % Chg

Allied Telesis Holdings KK

6835

156 +47.17%